1 Min Read
June 14 (Reuters) - Glenmark Pharmaceuticals Ltd
* Says receives tentative ANDA approval for saxagliptin tablets, 2.5 mg and 5 mg Source text - (bit.ly/2sqOx3e) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.